echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Announcement of the State Food and Drug Administration on Issuing the Principles for the Classification of Recombinant Collagen Medical Products (No. 27 of 2021)

    Announcement of the State Food and Drug Administration on Issuing the Principles for the Classification of Recombinant Collagen Medical Products (No. 27 of 2021)

    • Last Update: 2021-07-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In order to further strengthen the supervision and management of recombinant collagen medical products and promote the high-quality development of the industry, the State Food and Drug Administration has organized and formulated the "Principles for the Classification and Definition of Recombinant Collagen Medical Products", which is hereby announced


    Hereby inform



    Attachment: Principles of Classification and Definition of Recombinant Collagen Medical Products

    State Food and Drug Administration

    April 13, 2021



    Attachment to the Circular No.





    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.